Catalog No.
KDJ92702
Description
Ligelizumab is a humanized IgG1k monoclonal antibody targeted against immunoglobulin E (IgE). It is an IgE-directed monoclonal antibody under investigation for the treatment of chronic spontaneous urticaria (CSU).
Detection method
Colorimetric
Sample type
Plasma, Serum
Assay type
Quantitative
Range
78.125 - 5,000 ng/mL
Sensitivity
33.12 ng/mL
Precision
CV<20%
Recovery
80-120%
Shipping
2-8 ℃
Stability and Storage
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Alternative Names
CAS: 1322627-61-1, CL-2C
For research use only. Not for human or drug use.
